Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the second-highest quintile among peers.
BlackRock Health Sciences Opps Svc SHISX
- NAV / 1-Day Return 70.74 / +0.34 %
- Total Assets 8.4 Bil
-
Adj. Expense Ratio
- Expense Ratio 1.140%
- Distribution Fee Level Average
- Share Class Type No Load
- Category Health
- Investment Style Large Growth
- Min. Initial Investment 5,000
- Status Open
- TTM Yield 0.18%
- Turnover 29%
USD | NAV as of Jul 26, 2024 | 1-Day Return as of Jul 26, 2024, 10:17 PM GMT+0
Morningstar’s Analysis SHISX
Will SHISX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 48.8
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Eli Lilly and Co | 10.76 | 905.4 Mil | Healthcare |
UnitedHealth Group Inc | 7.91 | 665.9 Mil | Healthcare |
Boston Scientific Corp | 5.60 | 471.3 Mil | Healthcare |
AbbVie Inc | 4.02 | 338.5 Mil | Healthcare |
Amgen Inc | 3.83 | 322.2 Mil | Healthcare |
Merck & Co Inc | 3.78 | 318.0 Mil | Healthcare |
Thermo Fisher Scientific Inc | 3.40 | 286.0 Mil | Healthcare |
Danaher Corp | 3.23 | 271.5 Mil | Healthcare |
Intuitive Surgical Inc | 3.21 | 270.2 Mil | Healthcare |
Elevance Health Inc | 3.02 | 254.2 Mil | Healthcare |